Guru Ownership Trend
Guru Analysis for Aktis Oncology, Inc. (AKTS)
Aktis Oncology, Inc. (AKTS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.29 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $2.11 M net outflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 68.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Aktis Oncology, Inc. (AKTS)
Major holders include Steven Cohen ($2.59 M), Cliff Asness ($729,696), Renaissance Technologies (RenTech) ($594,594). According to the latest reported data, 3 tracked investment managers collectively hold approximately 200,903 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $2.11 M, with 1 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited AKTS. The total reported sell value was $4.69 M.
Yes, 1 managers opened new positions in AKTS, and 0 increased their existing holdings. The total reported buy value was $2.59 M.